Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model
Keywords:
Checkpoint inhibitors
HDAC inhibitor
Hepatocellular carcinoma
M1 macrophages
PD-1/PD-L1 expression
T regulatory cells
Citation:
Llopiz, D. (Diana); Ruiz, M. (Marta); Villanueva, L. (Lorea); et al. "Enhanced anti-tumor efficacy of checkpoint inhibitors in combination with the histone deacetylase inhibitor Belinostat in a murine hepatocellular carcinoma model". Cancer immunology, immunotherapy. 68 (3), 2019, 379 - 393
Statistics and impact
0 citas en
0 citas en
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.